These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 10853935)

  • 1. Experimental immune-mediated blepharoconjunctivitis in rats induced by immunization with ragweed pollen.
    Iwamoto H; Nishino K; Magone TM; Whitcup SM; Yoshida O; Yoshida H; Ozaki A; Fukushima A; Ueno H
    Graefes Arch Clin Exp Ophthalmol; 2000 Apr; 238(4):346-51. PubMed ID: 10853935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic background determines the nature of immune responses and experimental immune-mediated blepharoconjunctivitis (EC).
    Yoshida O; Yoshida H; Iwamoto H; Nishino K; Fukushima A; Ueno H
    Curr Eye Res; 1999 Feb; 18(2):117-24. PubMed ID: 10223655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the immunopathogenic responses to ovalbumin peptide 323-339 in experimental immune-mediated blepharoconjunctivitis in Lewis rats.
    Fukushima A; Nishino K; Yoshida O; Ueno H
    Curr Eye Res; 1998 Aug; 17(8):763-9. PubMed ID: 9723989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic background determines susceptibility to experimental immune-mediated blepharoconjunctivitis: comparison of Balb/c and C57BL/6 mice.
    Fukushima A; Yamaguchi T; Ishida W; Fukata K; Taniguchi T; Liu FT; Ueno H
    Exp Eye Res; 2006 Feb; 82(2):210-8. PubMed ID: 16102751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of IL-4 and IL-12 on experimental immune-mediated blepharoconjunctivitis in Brown Norway rats.
    Ozaki A; Fukushima A; Fukata K; Ueno H
    Clin Exp Immunol; 2000 Oct; 122(1):28-34. PubMed ID: 11012614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of genetic susceptibility to experimental allergic/immune-mediated blepharoconjunctivitis between Lewis and Fischer rats.
    Yoshida O; Yoshida H; Iwamoto H; Nishino K; Fukushima A; Ueno H
    Graefes Arch Clin Exp Ophthalmol; 1998 Nov; 236(11):859-64. PubMed ID: 9825262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of experimental immune-mediated blepharoconjunctivitis in Brown Norway rats by topical application of FK506.
    Nishino K; Fukushima A; Okamoto S; Ohashi Y; Fukata K; Ozaki A; Ueno H
    Graefes Arch Clin Exp Ophthalmol; 2002 Feb; 240(2):137-43. PubMed ID: 11931080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitory effects of FK506 on the development of experimental allergic/immune-mediated blepharoconjunctivitis in Lewis rats by systemic but not by topical administration.
    Iwamoto H; Yoshida H; Yoshida O; Fukushima A; Ueno H
    Graefes Arch Clin Exp Ophthalmol; 1999 May; 237(5):407-14. PubMed ID: 10333108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The immunization protocol determines whether endogenous interferon-gamma suppresses the infiltration of eosinophils into the conjunctiva.
    Fukushima A; Yamaguchi T; Ishida W; Fukata K; Ozaki A; Ueno H
    Immunol Lett; 2005 Sep; 100(2):189-94. PubMed ID: 15919119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dissection of antigen-specific humoral and cellular immune responses for the development of experimental immune-mediated blepharoconjunctivitis in C57BL/6 mice.
    Fukushima A; Ozaki A; Jian Z; Ishida W; Fukata K; Ueno H; Liu FT
    Curr Eye Res; 2005 Apr; 30(4):241-8. PubMed ID: 15823916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of cellular immunity both in the induction and effector phases of experimental allergic blepharoconjunctivitis (EAC) in rats.
    Fukushima A; Yoshida H; Iwamoto H; Yoshida O; Ueno H
    Exp Eye Res; 1997 Nov; 65(5):631-7. PubMed ID: 9367642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Roles of OX40 in the development of murine experimental allergic conjunctivitis: exacerbation and attenuation by stimulation and blocking of OX40.
    Fukushima A; Yamaguchi T; Ishida W; Fukata K; Yagita H; Ueno H
    Invest Ophthalmol Vis Sci; 2006 Feb; 47(2):657-63. PubMed ID: 16431965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ag-specific recognition, activation, and effector function of T cells in the conjunctiva with experimental immune-mediated blepharoconjunctivitis.
    Fukushima A; Ozaki A; Fukata K; Ishida W; Ueno H
    Invest Ophthalmol Vis Sci; 2003 Oct; 44(10):4366-74. PubMed ID: 14507881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of induction of experimental immune mediated blepharoconjunctivitis by tolerogenic conjugates of the antigen and monomethoxypolyethylene glycol.
    Fukushima A; Nishino K; Yoshida H; Takata M; Ueno H
    Br J Ophthalmol; 1999 Aug; 83(8):973-9. PubMed ID: 10413705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential expression and signaling of IFN-gamma in the conjunctiva between Lewis and Brown Norway rats.
    Fukushima A; Ozaki A; Fukata K; Ueno H
    Microbiol Immunol; 2003; 47(10):785-96. PubMed ID: 14605445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of effects of stimulation in vitro of ovalbumin primed lymph node cells on adoptive transfer of experimental immune mediated blepharoconjunctivitis in Lewis rats.
    Yoshida H; Yoshida O; Iwamoto H; Nishino K; Hashida M; Fukushima A; Ueno H
    Br J Ophthalmol; 1998 Oct; 82(10):1189-94. PubMed ID: 9924309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fyn regulates eosinophil infiltration into the conjunctiva by downregulating the Th2 response.
    Fukushima A; Yamaguchi T; Ozaki A; Taniguchi T; Udaka K; Ueno H
    Graefes Arch Clin Exp Ophthalmol; 2005 Oct; 243(10):1043-9. PubMed ID: 15838661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclosporin A inhibits eosinophilic infiltration into the conjunctiva mediated by type IV allergic reactions.
    Fukushima A; Yamaguchi T; Ishida W; Fukata K; Liu FT; Ueno H
    Clin Exp Ophthalmol; 2006; 34(4):347-53. PubMed ID: 16764655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Artificial tears inhibit the development of experimental immune-mediated blepharoconjunctivitis.
    Fukushima A; Zinchuk O; Ueno H
    Jpn J Ophthalmol; 2004; 48(6):530-4. PubMed ID: 15592776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exertion of the suppressive effects of IFN-gamma on experimental immune mediated blepharoconjunctivitis in Brown Norway rats during the induction phase but not the effector phase.
    Fukushima A; Fukata K; Ozaki A; Takata M; Kuroda N; Enzan H; Ueno H
    Br J Ophthalmol; 2002 Oct; 86(10):1166-71. PubMed ID: 12234900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.